These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7578742)

  • 41. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anidulafungin versus fluconazole for invasive candidiasis.
    Reboli AC; Rotstein C; Pappas PG; Chapman SW; Kett DH; Kumar D; Betts R; Wible M; Goldstein BP; Schranz J; Krause DS; Walsh TJ;
    N Engl J Med; 2007 Jun; 356(24):2472-82. PubMed ID: 17568028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic candidiasis in a dog.
    Heseltine JC; Panciera DL; Saunders GK
    J Am Vet Med Assoc; 2003 Sep; 223(6):821-4, 810. PubMed ID: 14507099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal prophylaxis with weekly fluconazole for patients with AIDS.
    Mylonakis E; Flanigan TP
    Clin Infect Dis; 1998 Dec; 27(6):1376-8. PubMed ID: 9868645
    [No Abstract]   [Full Text] [Related]  

  • 47. Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole.
    Kunová A; Trupl J; Spánik S; Drgona L; Sufliarsky J; Lacka J; Studená V; Hlavácová E; Studená M; Kukucková E
    Chemotherapy; 1995; 41(1):39-44. PubMed ID: 7875020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
    J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Could risk assessment for non-albicans Candida improve empiric treatment for invasive candidiasis?
    Drew RH
    Ann Pharmacother; 2007 Apr; 41(4):690-2. PubMed ID: 17389669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus.
    Patel PN; Sah P; Chandrashekar C; Vidyasagar S; Venkata Rao J; Tiwari M; Radhakrishnan R
    Diabetes Res Clin Pract; 2017 Mar; 125():10-19. PubMed ID: 28131069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
    Pasqualotto AC; Zimerman RA; Alves SH; Aquino VR; Branco D; Wiltgen D; do Amaral A; Cechinel R; Colares SM; da Rocha IG; Severo LC; Sukiennik TC
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):898-9. PubMed ID: 18785850
    [No Abstract]   [Full Text] [Related]  

  • 57. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
    Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
    Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candida norvegensis fungemia in a liver transplant recipient.
    Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
    Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.